Life Sciences Cases To Watch In 2014

Law360, New York (January 1, 2014, 10:08 AM EST) -- Pharmaceutical manufacturers in 2014 will be glued to a high-stakes tussle in federal court over the Federal Trade Commission’s power to punish pay-for-delay deals, while the U.S. Supreme Court has the chance to put to rest muddied questions on False Claims Act pleading standards and off-label drug promotion.

The next 12 months could also reshape the landscape for patent protection on lucrative genetic diagnostic products and open up device makers to a new breed of tort claims. Here are six cases life sciences attorneys would be...